7 peptides under active FDA review PCAC MEETING IN 15 DAYS
FindLegitPeptides status board · v2.4.0
NAD+ (compounded)
nicotinamide adenine dinucleotide, injectable
Cat 2 restricted

No. Not currently eligible for pharmacy compounding.

Pending verification

Talk to a licensed clinician before acting on this.

Category 2 (FDA proposed NOT to add to the 503A bulks list)

Longevity
Sources: FDA

Same category

Related peptides

Before you spend a dollar: confirm the pharmacy is real, and know what a fair price looks like.